In the intricate landscape of pharmaceutical research and development, the availability of reliable and high-purity intermediates is fundamental to success. [3-(9H-Carbazol-9-yl)phenyl]boronic Acid (CAS: 864377-33-3) stands out as a valuable pharmaceutical intermediate, playing a critical role in the synthesis of diverse drug candidates. NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to supplying this essential compound to the global pharmaceutical industry.
The carbazole moiety is present in numerous biologically active molecules, often contributing to their pharmacological properties. When functionalized with a boronic acid group, as in [3-(9H-Carbazol-9-yl)phenyl]boronic Acid, it becomes an exceptionally useful building block for medicinal chemists. Its incorporation into molecular structures can influence parameters such as receptor binding affinity, metabolic stability, and overall efficacy. The ability to readily perform Suzuki-Miyaura couplings with this compound facilitates the efficient construction of complex pharmaceutical scaffolds. This is why many researchers are keen to buy [3-(9H-Carbazol-9-yl)phenyl]boronic acid for their drug discovery programs.
The journey from initial compound screening to an approved drug is long and complex, with each step relying on the quality of the starting materials and intermediates. The high purity of [3-(9H-Carbazol-9-yl)phenyl]boronic Acid, as supplied by NINGBO INNO PHARMCHEM CO.,LTD., ensures that synthetic routes are reproducible and that the final active pharmaceutical ingredients (APIs) meet stringent regulatory standards. This makes it a preferred choice for companies engaged in both early-stage research and later-stage process development.
Furthermore, the chemical stability and reactivity profile of [3-(9H-Carbazol-9-yl)phenyl]boronic Acid make it amenable to various synthetic methodologies commonly employed in pharmaceutical manufacturing. Its availability as a white powder with a minimum purity of 97% underscores its suitability for use in GMP (Good Manufacturing Practice) environments. NINGBO INNO PHARMCHEM CO.,LTD. understands the critical nature of consistent quality and supply chain reliability for pharmaceutical clients.
In conclusion, [3-(9H-Carbazol-9-yl)phenyl]boronic Acid is a testament to the power of functionalized intermediates in advancing pharmaceutical science. Its utility in building novel therapeutic agents makes it an indispensable component in the modern drug discovery pipeline. For those seeking a dependable supplier of this vital pharmaceutical intermediate, NINGBO INNO PHARMCHEM CO.,LTD. offers the quality and expertise needed to support your critical research and development efforts.
Manufacturing Facilities






Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.